Oruka Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Menlo Park, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Oruka Therapeutics, Inc. has filed 1,498 SEC EDGAR filings since 12 Jun 1997

SEC filing history

Showing 1-15 of 15 matching filings.

Per page
25
Current page
1
SC 13D/A File 005-51477

AMENDMENT NO. 2 TO SCHEDULE 13D

Filing date
21 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-51477

SC 13D/A filing

Filing date
22 Oct 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-51477

AMENDMENT NO. 1 TO SCHEDULE 13D

Filing date
13 Sep 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-51477

SCHEDULE 13D

Filing date
06 Sep 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-51477

ARCA BIOPHARMA, INC.

Filing date
05 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-51477

AMENDMENT NO. 6 TO THE SCHEDULE 13D

Filing date
08 Jul 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-51477

AMENDMENT NO. 5 TO THE SCHEDULE 13D

Filing date
21 Jun 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-51477

AMENDMENT NO. 4 TO THE SCHEDULE 13D

Filing date
27 May 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-51477

AMENDMENT NO. 3 TO THE SCHEDULE 13D

Filing date
11 May 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-51477

AMENDMENT NO. 2 TO THE SCHEDULE 13D

Filing date
14 Apr 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-51477

AMENDMENT NO. 1 TO THE SCHEDULE 13D

Filing date
04 Apr 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-51477

THE SCHEDULE 13D

Filing date
28 Mar 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-51477

GROWTH EQUITY OPPORTUNITIES FUND IV, LLC --- ARCA BIOPHARMA, INC. - SCHEDULE 13D

Filing date
05 Mar 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-51477

ARCA BIOPHARMA, INC.

Filing date
29 Jun 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-51477

SC 13D

Filing date
02 Nov 2012
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .